CorMedix
CRMD
137 hedge funds and large institutions have $146M invested in CorMedix in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 35 reducing their positions, and 17 closing their positions.
59% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 17
43% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 35
6% more funds holding
Funds holding: 129 → 137 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.38% less ownership
Funds ownership: 37.83% → 36.45% (-1.4%)
19% less call options, than puts
Call options by funds: $4.77M | Put options by funds: $5.89M
21% less capital invested
Capital invested by funds: $186M → $146M (-$39.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$5.02M |
| 2 |
Morgan Stanley
New York
|
+$3.16M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.06M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.78M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTM
First Turn Management
Del Mar,
California
|
-$8.27M |
| 2 |
EIM
Elliott Investment Management
West Palm Beach,
Florida
|
-$4.41M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$3.7M |
| 4 |
JP Morgan Chase
New York
|
-$2.45M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$2.3M |
CRMD Hedge Fund Activity: Q1 2025 in Review
137 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2025, worth a combined $146M — down 21% from $186M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CRMD positions and 17 closed out — a net gain of 10 holders — while 50 added to existing stakes and 35 trimmed.
The largest buyer was Oberweis Asset Management, opening a new position worth an estimated $5.02M. The largest seller was First Turn Management, exiting entirely with an estimated $8.27M sold.
- 137 institutional investors held CorMedix (CRMD) as of Q1 2025, up from 129 in Q4 2024.
- Funds reported $146M of CorMedix stock for Q1 2025, down 21% quarter-over-quarter.
- 27 funds opened new CorMedix positions in Q1 2025 and 17 closed out, a net change of +10 holders.
- The largest CorMedix buyer in Q1 2025 was Oberweis Asset Management, an estimated $5.02M added.
- The largest CorMedix seller in Q1 2025 was First Turn Management, an estimated $8.27M sold.
Based on aggregated 13F filings for Q1 2025.